Affordable Access

deepdyve-link
Publisher Website

Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy.

Authors
  • Verdoia, Monica1
  • Pergolini, Patrizia2
  • Rolla, Roberta2
  • Nardin, Matteo1
  • Barbieri, Lucia1
  • Daffara, Veronica1
  • Marino, Paolo1
  • Bellomo, Giorgio2
  • Suryapranata, Harry3
  • Luca, Giuseppe De4
  • 1 Department of Cardiology, Ospedale "Maggiore della Carità", Eastern Piedmont University, C.so Mazzini, 18, 28100, Novara, Italy. , (Italy)
  • 2 Clinical Chemistry, Ospedale "Maggiore della Carità", Eastern Piedmont University, Novara, Italy. , (Italy)
  • 3 Cardiology, UMC St Radboud, Nijmegen, The Netherlands. , (Netherlands)
  • 4 Department of Cardiology, Ospedale "Maggiore della Carità", Eastern Piedmont University, C.so Mazzini, 18, 28100, Novara, Italy. [email protected] , (Italy)
Type
Published Article
Journal
Cardiovascular drugs and therapy
Publication Date
April 2016
Volume
30
Issue
2
Pages
143–150
Identifiers
DOI: 10.1007/s10557-016-6646-5
PMID: 26868495
Source
Medline
Keywords
License
Unknown

Abstract

In patients receiving dual antiplatelet therapy, gender does not impact on the prevalence of high-on treatment residual platelet reactivity (HRPR) with the major antiplatelet agents ASA, clopidogrel or ticagrelor.

Report this publication

Statistics

Seen <100 times